Medicare Enrolled
Dr. John Regan, M.D.
Urology Physician · Champaign, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Regan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Regan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Regan
Dr. John Regan is an urology physician in Champaign, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Regan performed 1,896 Medicare services across 1,414 unique beneficiaries.
Between the years covered by Open Payments, Dr. Regan received a total of $7,162 from 54 pharmaceutical and/or device companies across 371 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Regan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 45% volume in IL
$7,162 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,896
Medicare services
Top 45% in IL for urology physician
1,414
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~100 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
401 | $84 | $252 |
| PSA test (prostate cancer screening) | 312 | $18 | $172 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
293 | $8 | $32 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
189 | $58 | $171 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 117 | $136 | $1,693 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
93 | $167 | $803 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
91 | $7 | $92 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
69 | $119 | $393 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
50 | $42 | $109 |
| Injection, garamycin, gentamicin, up to 80 mg | 44 | $2 | $16 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
43 | $8 | $95 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
39 | $8 | $82 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
24 | $162 | $786 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
22 | $23 | $108 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
19 | $103 | $1,490 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
19 | $4 | $40 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
17 | $25 | $170 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
17 | $8 | $67 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $82 | $258 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
11 | $19 | $311 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
11 | $41 | $3,037 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,162
Total received (2018-2024)
Avg $1,023/year across 7 years
Top 24% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
371
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,988 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$173 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,668
2023
$1,266
2022
$1,125
2021
$877
2020
$402
2019
$819
2018
$1,005
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$350
Sumitomo Pharma America, Inc.
$213
Astellas Pharma US Inc
$146
PFIZER INC.
$141
Becton, Dickinson and Company
$129
Ferring Pharmaceuticals Inc.
$121
ABBVIE INC.
$84
Endo USA, Inc.
$74
Tolmar, Inc.
$59
Teleflex LLC
$52
COLOPLAST CORP
$47
Boston Scientific Corporation
$36
Dendreon Pharmaceuticals LLC
$33
PROCEPT BioRobotics Corporation
$29
Merck Sharp & Dohme LLC
$23
Myriad Genetic Laboratories, Inc.
$23
AstraZeneca Pharmaceuticals LP
$21
Olympus America Inc.
$19
KOELIS Inc.
$18
PROGENICS PHARMACEUTICALS, INC.
$18
Bayer Healthcare Pharmaceuticals Inc.
$18
Axonics, Inc.
$14
Top 3 companies account for 42.5% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$1,621
Astellas Pharma US Inc
$1,045
PFIZER INC.
$365
Endo Pharmaceuticals Inc.
$347
Sumitomo Pharma America, Inc.
$264
Rochester Medical Corporation
$204
ABBVIE INC.
$197
Merck Sharp & Dohme LLC
$196
NeoTract Inc.
$187
AbbVie, Inc.
$186
Boston Scientific Corporation
$170
Myriad Genetic Laboratories, Inc.
$157
TOLMAR Pharmaceuticals, Inc.
$151
Bayer HealthCare Pharmaceuticals Inc.
$150
Becton, Dickinson and Company
$129
Ferring Pharmaceuticals Inc.
$121
COLOPLAST CORP
$101
Janssen Products, LP
$100
Blue Earth Diagnostics Limited
$100
180 Medical, Inc.
$99
Teleflex LLC
$89
Tolmar, Inc.
$79
Olympus America Inc.
$77
AstraZeneca Pharmaceuticals LP
$77
Endo USA, Inc.
$74
AbbVie Inc.
$72
Avadel Specialty Pharmaceuticals, LLC
$62
UROVANT SCIENCES INC
$61
Coloplast Corp
$47
Hollister Incorporated
$46
C. R. Bard, Inc. & Subsidiaries
$46
PROCEPT BioRobotics Corporation
$43
Bayer Healthcare Pharmaceuticals Inc.
$42
Progenics Pharmaceuticals, Inc.
$41
ConvaTec Inc.
$38
Merck Sharp & Dohme Corporation
$33
Dendreon Pharmaceuticals LLC
$33
UroGen Pharma, Inc.
$32
Dornier MedTech America, Inc
$31
TherapeuticsMD, Inc.
$26
Allergan Inc.
$22
Palette Life Sciences, Inc.
$20
Photocure Inc
$19
KOELIS Inc.
$18
PROGENICS PHARMACEUTICALS, INC.
$18
Smith+Nephew, Inc.
$17
Cook Incorporated
$17
NxThera, Inc.
$15
Axonics, Inc.
$14
KARL STORZ Endoscopy-America
$14
BOSTON SCIENTIFIC CORPORATION
$13
Augmenix, Inc.
$13
Cook Medical LLC
$12
MEDIVATION FIELD SOLUTIONS LLC
$11
Top 3 companies account for 42.3% of all-time payments
Associated products mentioned in payments ›
AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Androgel · Axonics · Axumin · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · COOK MEDICAL WIRE GUIDES · Cook Medical Stents · Cysview · EDEX · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL ONCOLOGY · GENERAL THERAPIES · GENERAL - BPH · GENTLECATH · GentleCath · HD-VIEW · IMVEXXY · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · LithoVue · Lithotripters & Accessories · Luja Coude · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · MYRISK · Myrbetriq · Noctiva · Nubeqa · ORGOVYX · Olympus Cystoscopes · PROLARIS · PROVENGE · PYLARIFY · Prolaris · REZUM · Rezum · SPEEDICATH · Soltive · SpaceOAR · SpaceOAR VUE System - 10mL · SpeediCath · Stravix · Titan · Trinity · UROLIFT · UroLift · VAPRO · VESICARE · VaPro Plus Pocket · Veozah · Virtue · XIAFLEX · XTANDI · Xofigo · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
15
Per 100K population
7.3
County median income
$63,091
Nearest hospital
THE PAVILION
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Regan is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Regan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Regan performed 401 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Regan receive payments from pharmaceutical companies?
Yes. Dr. Regan received a total of $7,162 from 54 companies across 371 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Regan's costs compare to other urology physicians in Champaign?
Dr. Regan's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Regan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Champaign
Browse urology physicians in Champaign ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology